On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
Press Release issued by African Centre for Biodiversity, Third World Network and GeneWatch UK
Johannesburg, 9 November 2018
Release of risky GM mosquitoes in Burkina Faso highly unethical
Huge technical advances in molecular biology and big data biology are leading us towards a ‘forth industrial revolution’ with the ongoing development of novel genetic engineering techniques being reviewed by the UN Conventions for Biological Diversity, under the term ‘synthetic biology’.
Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release.
In this briefing paper ACB, TWN and GeneWatch UK discuss that genetically modified (GM) mosquitoes were exported from Imperial College in London to Burkina Faso in November 2016. They are currently in “contained use” facilities in Bobo-Dioulasso, and are being used in experiments by a research consortium called Target Malaria.
After 5 seasons of genetically modified (GM) cotton cultivation in Burkina Faso farmers are denouncing their contracts with Monsanto and cotton stakeholders are discussing compensation for losses incurred since 2008 due to low yields and low quality fibre.
The Africa Centre for Biosafety (ACB) has dismissed the findings of the biotechnology industry's flagship annual report, published by the GM industry funded 'NGO', the International Service for the Acquisition of Agri-biotech Applications (ISAAA), as mischievous and erroneous.